URI
69
3
STZ
52
3
LLY
56
2
FLR
60
-2
UNP
49
3
AKAM
64
-2
DHR
44
-7
SJM
28
-8
PNW
70
4
R
57
-2
AAP
27
-8
HPE
51
-2
EMC
65
-3
GS
62
3
PH
60
-7
JWN
55
-5
MOS
50
14
ETN
78
-2
JCI
52
-2
CHRW
42
-3
URI
69
3
STZ
52
3
LLY
56
2
FLR
60
-2
UNP
49
3
AKAM
64
-2
DHR
44
-7
SJM
28
-8
PNW
70
4
R
57
-2
AAP
27
-8
HPE
51
-2
EMC
65
-3
GS
62
3
PH
60
-7
JWN
55
-5
MOS
50
14
ETN
78
-2
JCI
52
-2
CHRW
42
-3
Financhill
Back

UroGen Pharma Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Buy
51

URGN
UroGen Pharma

Last Price:
12.42
Seasonality Move:
14.66%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.58
Seasonality Move:
-16.74%
Buy
51
UroGen Pharma (URGN) is a Buy

Is UroGen Pharma a Buy, Sell or Hold?

  • The current UroGen Pharma [URGN] share price is $12.47. The Score for URGN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • URGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.59. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

URGN Stock Price Chart

What is UroGen Pharma's stock price today?

  • The UroGen Pharma share price today is $12.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

URGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 45.42 Sell
Chaikin Money Flow: 215195 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.27 - 13.13) Sell
Bollinger Bands (100): (12.84 - 16.3) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 42.74 Sell
Chaikin Money Flow: 36308 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.72) Sell
Bollinger Bands (100): (0.35 - 2.23) Sell

URGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.42 Buy
20-day SMA: 12.56 Sell
50-day SMA: 13.41 Sell
200-day SMA: 14.93 Sell
8-day EMA: 12.49 Sell
20-day EMA: 12.65 Sell
50-day EMA: 13.34 Sell
200-day EMA: 14.25 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Sell
20-day SMA: 0.66 Sell
50-day SMA: 0.57 Buy
200-day SMA: 2.9 Sell
8-day EMA: 0.62 Sell
20-day EMA: 0.63 Sell
50-day EMA: 0.78 Sell
200-day EMA: 6.83 Sell

UroGen Pharma Earnings Growth & URGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.62 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

UroGen Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):